Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 trial evaluating vaccine therapy plus interleukin-2 in patients with follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Idiotype vaccine (follicular lymphoma)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 1 | Status: COMPLETED